INTRODUCTION
Wolfram syndrome (WS) is an autosomal recessive neurodegenerative disease with an estimated prevalence varying worldwide from 1 in 68,000 to 1 in 770,000 (Barrett & Bundey 1997; Kumar 2010) . Clinical manifestations include diabetes mellitus, optic nerve atrophy, diabetes insipidus, sensorineural hearing loss (SNHL), neurological symptoms, renal tract abnormalities, psychiatric disorders, and gonadal disorders. The disease is fatal with death usually occurring before 50 years of age (Barrett & Bundey 1997) .
Hearing loss of some degree is observed in at least 62 to 72% of patients with WS (Higashi 1991; Kumar 2010) . The most commonly reported presentation of hearing loss in WS is a high-frequency SNHL that is typically diagnosed during the second or third decade of life (Supplemental Digital Content 1, Table, http://links.lww.com/EANDH/A105, which provides data and references from series and case reports). However, with notable exceptions (Pennings et al. 2004; Plantinga et al. 2008; Hilson et al. 2009 ), the majority of published reports do not include sufficient details about the audiologic measures used to specify the severity or progression of hearing loss in WS. Because there are very few reports of vestibular function in patients with WS and even fewer in which both auditory and vestibular function are measured, the relationship between balance and auditory function remains uncertain.
The intent of this study was to assess auditory and vestibular function in an international cohort of patients with WS, using a fixed protocol of standardized tests. The test battery includes traditional tests of auditory and vestibular function, as well as audiologic tests that have not been reported previously in this clinical population, such as measures of distortion product otoacoustic emissions (DPOAEs), and speech-in-noise (SIN) as well as calculation of the Speech Intelligibility Index (SII). The same protocol will be applied during yearly follow-up assessments of these patients and compared with the baseline measures reported here. Such a comparison will assist in determining the patterns and progression of hearing and vestibular loss in patients who have WS.
PARTICIPANTS AND METHODS

Participants
Audiologic testing was administered to 11 patients (5.8 to 23.8 years of age). Of the 11 patients, 3 (W03, W04 and W12) wore bilateral hearing aids (HAs) and 1 (W05) had bilateral cochlear implants (CIs). Because of time constraints, 3 patients (W05, W07, and W13) were unable to participate in vestibular testing and limited audiologic assessment was conducted with W05. Three patients (W09, W10, and W11) were siblings. W07 had a first cousin and two distant cousins with WS who were not included in the cohort.
Procedures
Audiologic testing included otoscopic inspection, pure tones (0.25 to 8 kHz), tympanometry, DPOAEs, unaided speech-reception thresholds (SRTs), and unaided testing of SIN. SII scores were calculated for each ear based on pure-tone test results in the unaided condition (American National Standards Institute S3.5-1997). Unaided assessment refers to testing completed without the use of HAs (W03, W04, and W12) or CIs (W05).
Hearing sensitivity was considered abnormal if the air conduction pure-tone average (PTA) of 0.50, 1, and 2 kHz was greater than 20 dB HL or two or more frequencies were greater than 20 dB HL. Bone conduction thresholds were assessed if the air conduction thresholds were greater than or equal to 20 dB HL. DPOAEs, which assess outer hair cell function in the cochlea, were measured and analyzed for 2, 3, and 4 kHz. Criterion for normal DPOAEs was greater than or equal to the 10th percentile (Gorga et al. 2005) , that is −9.82 dB SPL at 2 kHz, −11.50 dB SPL at 3 kHz, and −5.93 dB SPL at 4 kHz with signal to noise ratio (SNR) of 6 dB or higher.
SRTs were obtained with the Central Institute for the Deaf W1 spondee word list via recorded test stimuli. SNR-50 scores for the Bamford-Kowal-Bench Speech-in-Noise (BKB-SIN) test were considered normal if they fell within 2 SD of the mean using the following published criteria: 5 to 6 years (mean = 3.5 dB; SD = 2.0 dB); 7 to 10 years (mean = 0.8 dB; SD = 2.0 dB); 11 to 14 years (mean = −0.9 dB; SD = 1.1 dB); adults (mean = −2.5 dB; SD = 0.8 dB) (Etymotic Research, Inc. 2005) .
Vestibular testing consisted of stimuli presented at 0.025, 0.05, 0.25, and 0.5 Hz at a peak velocity of 60°/second in a standard clinical rotary test chair. The same chair was used to measure responses to rotational impulses using velocity steps of 100°/second acceleration.
Instrumentation
Testing was conducted in a sound-treated room (Industrial Acoustics Company, Inc., New York, NY). Auditory stimuli were presented with the Madsen Orbiter-922 audiometer calibrated to American National Standards Institute (S3. via sound field, insert earphones, or a bone conduction oscillator. Tympanometric measures were obtained with the Madsen Zodiac 901. DPOAE measures were obtained with the Interacoustics OtoRead, with f 1 set to 65 dB SPL and f 2 set to 55 dB SPL. The SII was calculated on the Audioscan Verifit.
Vestibular testing was performed with a rotational chair (System 2000; Micromedical Technologies, Chatham, IL).
RESULTS
Fifty-five percent of the patients had SNHL. Mean age of diagnosis for SNHL was 7.3 years for our cohort (Supplemental Digital Content 2, see Table, http://links.lww.com/EANDH/ A106, which shows age at diagnosis of SNHL relative to diabetes mellitus, diabetes insipidus, and optic nerve atrophy). In most cases the exact age of onset was unknown. Audiograms for 4 patients with SNHL are shown in Figure 1 . Not shown are data for W05, who has profound bilateral hearing loss diagnosed at 20 months of age and has bilateral CIs, W11, who exhibited slight to mild mixed hearing loss, with a transient conductive component, W07 who had a unilateral transient conductive loss, and those patients with normal bilateral hearing (W02, W09, W10, and W13). With the exception of W05, patients less than 15 years of age had PTAs less than 20 dB HL for the better ear, compared with patients greater than 15 years of age who had PTAs of 28.3 to 58.3 dB HL for the better ear (Supplemental Digital Content 3, Table, http://links.lww.com/EANDH/A107, which shows PTA, high-frequency average, hearing status, SII, and BKB-SIN results).
SII scores ranged from 0.0 (no speech cues audible) to 1.0 (all speech cues audible). Of the four patients with SII less than 0.75 for the better ear, W05 relies on bilateral CIs, and W03, W04, and W12 wear bilateral HAs. DPOAEs were reasonably consistent with pure-tone thresholds (Supplemental Digital Content 4, Table, http://links.lww.com/EANDH/A108, which shows DPOAE data).
Unexpectedly, W10 and W13, both of whom had normalhearing (NH) sensitivity, produced abnormal BKB-SIN scores with an SNR-50 of 3.0 for W10 and 9.0 for W13, suggestive of difficulty listening in noise. Both W10 and W13 were subsequently tested with speech in quiet at 40 dB SL re: SRT. W10, tested with Central Institute for the Deaf W22, had normal scores (96% for both ears). Likewise, W13's testing with Word Intelligibility by Picture Index (Ross & Lerman 1971) resulted in normal scores (94% right ear, 96% left ear). As anticipated, patients with significant hearing loss (W03, W04, and W12) had SII less than 0.75 and abnormal SNR-50 scores on the BKB-SIN.
Results of sinusoidal vestibular and step velocity testing are shown in Figure 2 . W04 had abnormally low gains, and W02 and W09 had borderline low gains across frequencies tested. All patients had normal or near-normal phase leads, with the exception of W04, whose low-frequency phase lead was pathologically elevated. On step velocity testing, W02, W09, and W04 all had borderline low gains in at least one direction and W04 had a markedly decreased time constant in both directions.
DISCUSSION
Although prevalence of SNHL (55%) in our cohort was consistent with existing reports, the average age at diagnosis of SNHL for our cohort was 7.3 years, which is younger than in most previous studies (Kumar 2010; Supplemental Digital Content 1, Table, http://links.lww.com/EANDH/A105, which provides data and references from series and case reports). Plausible explanations include diagnostic criteria, the young age of the cohort, and variable expression or penetrance. W05 and at least 10 previously reported patients had diagnosis of SNHL from birth to 3 years of age (Supplemental Digital Content 1, Table, http://links.lww.com/EANDH/A105, which provides data and references from series and case reports). Because SNHL can be the first symptom of WS, audiologists and otolaryngologists should recommend that patients are checked periodically for diabetes and vision conditions in young patients with SNHL.
According to previous studies, hearing loss is under-reported if it is based on patient or parent report rather than audiometric measures (Barrett & Bundey 1997; Simsek et al. 2003; Lombardo et al. 2005; Kumar 2010 ). In our cohort, no hearing difficulty was reported for W01 and W11; however, both were diagnosed with hearing loss based on pure-tone testing. Because the hearing loss in WS typically affects the high frequencies first and usually progresses slowly, age at diagnosis may be delayed by months or years relative to age of onset.
Although SNHL configurations were variable in our cohort, hearing loss was symmetrical, with all patients exhibiting highfrequency loss (Fig. 1) . As in the study by Hansen et al. (2005) , conductive components were observed in 2 patients (W07 and W11). Subsequent testing of these patients indicated that the conductive components were transient.
The BKB-SIN was administered to represent auditory challenges based in everyday communication. Unexpectedly, 2 NH patients (W10 and W13) had abnormal BKB-SIN scores. Factors that may have contributed include fatigue and reduced speech/language ability. It is also possible that the test is accurately portraying poorer SIN performance with this population. Follow-up speech testing with these patients is necessary to verify this finding.
With respect to treatment, Hilson et al. (2009) reported that HA use was unsuccessful, but our data suggest otherwise. All 4 patients in our cohort with SII less than 0.75 use bilateral amplification devices. W03, W04, and W12 wear HAs and 1 W05 has CIs. Although hearing benefit was not formally assessed, the routine use of the devices by these patients is a subjective indicator of benefit.
With respect to vestibular assessment, rotational chair testing indicated profound vestibular loss in W04, who was the oldest patient in the study (23.8 years of age), although vestibular function was normal in W12, who was of the same approximate age. In addition to vestibular loss, W04 had a moderate to severe SNHL with an unusual audiometric configuration-significant low-frequency hearing loss as well as the more common highfrequency loss typical of WS. Of patients who received vestibular testing, W04 had the poorest PTA for both ears.
Our finding that profound bilateral vestibular loss was not common is typical of patients with WS (Higashi 1991; Megighian & Savastano 2004; Pennings et al. 2004 ). Hilson et al. (2009) reported temporal bone evidence for hair cell loss in the basal turn of the cochlea, typical of high-frequency hearing loss, but intact vestibular sense organs. Only one study has reported more vestibular dysfunction than hearing loss. Barjon et al. (1964) evaluated 3 patients and described bilateral vestibular loss both in a patient with a moderate SNHL across a wide range of frequencies (similar to findings for W04) and in a patient with essentially NH. Overall, the findings of the present study and previous works suggest that vestibular loss may be more likely to occur in patients with a low-frequency component to their hearing loss.
Our study is limited because we did not include auditory brainstem response (ABR) testing. Systematic, longitudinal ABR data with a sufficient sample size are needed to determine the relationship between ABR neurologic measures such as interpeak latencies and rate studies relative to neuroaudiologic findings and clinical neurological symptoms. ABR assessment will be added to the test protocol for future years.
Although preliminary, the results of this study suggest that (1) the onset of hearing loss in WS may occur earlier than what has been reported previously; (2) HAs may be beneficial in patients with WS; (3) some WS patients with NH may have difficulty with SIN tasks; and (4) WS patients who have both low-and high-frequency SNHL may be more likely to have vestibular dysfunction. Audiologic and vestibular function will continue to be monitored in this cohort to determine whether changes in function occur over time.
